JAK2	NN
mediates	VBZ
lung	NN
fibrosis	NN
,	,
pulmonary	JJ
vascular	JJ
remodelling	NN
and	CC
hypertension	NN
in	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
:	:
an	DT
experimental	JJ
study	NN
.	.

BACKGROUND	NN
:	:
Pulmonary	JJ
hypertension	NN
(	(
PH	NN
)	)
is	VBZ
a	DT
common	JJ
disorder	NN
in	IN
patients	NNS
with	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
and	CC
portends	VBZ
a	DT
poor	JJ
prognosis	NN
.	.

Recent	JJ
studies	NNS
using	VBG
vasodilators	NNS
approved	VBN
for	IN
PH	NN
have	VBP
failed	VBN
in	IN
improving	VBG
IPF	NN
mainly	RB
due	JJ
to	TO
ventilation	NN
(	(
V	NN
)	)
/	:
perfusion	NN
(	(
Q	NNP
)	)
mismatching	VBG
and	CC
oxygen	NN
desaturation	NN
.	.

Janus-kinase-type-2	NN
(	(
JAK2	NN
)	)
is	VBZ
a	DT
non-receptor	JJ
tyrosine	NN
kinase	NN
activated	VBN
by	IN
a	DT
broad	JJ
spectrum	NN
of	IN
profibrotic	JJ
and	CC
vasoactive	JJ
mediators	NNS
,	,
but	CC
its	PRP$
role	NN
in	IN
PH	NN
associated	VBN
to	TO
PH	NN
is	VBZ
unknown	JJ
.	.

OBJECTIVE	NN
:	:
The	DT
study	NN
of	IN
JAK2	NN
as	IN
potential	JJ
target	NN
to	TO
treat	VB
PH	NNP
in	IN
IPF	NNP
.	.

METHODS	NNS
AND	CC
RESULTS	NNS
:	:
JAK2	NN
expression	NN
was	VBD
increased	VBN
in	IN
pulmonary	JJ
arteries	NNS
(	(
PAs	NNS
)	)
from	IN
IPF	NN
(	(
n	NN
=	JJ
10	CD
;	:
1.93-fold	RB
;	:
P	NN
=	JJ
0.0011	CD
)	)
and	CC
IPF+PH	NN
(	(
n	NN
=	JJ
9	CD
;	:
2.65-fold	RB
;	:
P	NN
<	JJR
0.0001	CD
)	)
compared	VBN
with	IN
PA	NN
from	IN
control	JJ
subjects	NNS
(	(
n	NN
=	JJ
10	CD
)	)
.	.

PA	NN
remodelling	NN
was	VBD
evaluated	VBN
in	IN
human	JJ
pulmonary	JJ
artery	NN
endothelial	JJ
cells	NNS
(	(
HPAECs	NNS
)	)
and	CC
human	JJ
pulmonary	JJ
artery	NN
smooth	JJ
muscle	NN
cells	NNS
(	(
HPASMCs	NNS
)	)
from	IN
patients	NNS
with	IN
IPF	NN
in	FW
vitro	FW
treated	VBN
with	IN
the	DT
JAK2	NN
inhibitor	NN
JSI-124	NN
or	CC
siRNA-JAK2	NN
and	CC
stimulated	VBN
with	IN
transforming-growth-factor-beta	NN
.	.

Both	DT
JSI-124	NN
and	CC
siRNA-JAK2	NN
inhibited	VBD
the	DT
HPAEC	NN
to	TO
mesenchymal	JJ
transition	NN
and	CC
the	DT
HPASMCs	NNS
to	TO
myofibroblast	JJ
transition	NN
and	CC
proliferation	NN
.	.

JAK2	NN
inhibition	NN
induced	VBD
small	JJ
PA	NN
relaxation	NN
in	IN
precision-cut	JJ
lung	NN
slice	NN
experiments	NNS
.	.

PA	NN
relaxation	NN
was	VBD
dependent	JJ
of	IN
the	DT
large	JJ
conductance	NN
calcium-activated	JJ
potassium	NN
channel	NN
(	(
BK	NN
<sub>	NN
Ca	NN
</sub>	NN
)	)
.	.

JAK2	NN
inhibition	NN
activated	VBD
BK	NN
<sub>	NN
Ca	NN
</sub>	NN
channels	NNS
and	CC
reduced	VBN
intracellular	JJ
Ca	NN
<sup>	NN
2	CD
+	CC
</sup>	NN
.	.

JSI-124	NN
1	CD
mg/kg/day	NN
,	,
reduced	VBD
bleomycin-induced	JJ
lung	NN
fibrosis	NN
,	,
PA	NN
remodelling	NN
,	,
right	JJ
ventricular	JJ
hypertrophy	NN
,	,
PA	NN
hypertension	NN
andV/Qmismatching	NN
in	IN
rats	NNS
.	.

The	DT
animal	NN
studies	NNS
followed	VBD
the	DT
ARRIVE	NNP
guidelines	NNS
.	.

CONCLUSIONS	NNS
:	:
JAK2	NN
participates	VBZ
in	IN
PA	NN
remodelling	NN
and	CC
tension	NN
and	CC
may	MD
be	VB
an	DT
attractive	JJ
target	NN
to	TO
treat	VB
IPF	NN
associated	VBN
to	TO
PH.	NNP
